Guaifenesin Market Size, Share, Industry Growth & Forecast Analysis

Global Guaifenesin Market Size, Share, Growth, Industry Trends, Competitive Analysis and Forecast to 2030

Report ID: RC94613 | Report Format: PDF + Excel | Starting Price: 3600/- USD |

The global guaifenesin market size is anticipated to register a significant CAGR of 2.7% over the forecast period from 2021 to 2027 and estimated to reach USD 505 million by 2027. The significant increase in the number of patients suffering with chest congestion as a result of common cold, influenza and other lower respiratory tract infection worldwide. Additionally the availability of the over the counter (OTC) drug formulation containing guaifenesin in combination with other drugs will further accentuates the market growth.

Guaifenesin is categorized as an expectorant which enhances the removal of phlegm and bronchial secretions by reducing the adhesiveness and viscosity of mucus, thereby facilitates the efficacy of mucociliary action in order to remove the mucus from the upper and lower respiratory tract.

Market Segment Insights:

Chest congestion is spearheading the clinical application segment for guaifenesin market. The common causes associated with chest congestion are common cold, influenza, asthma, bronchitis, allergic reactions etc. Mucus is present in the body which secretes more as a consequence of lower respiratory tract infection which can lead to coughing and pain. Expectorants are beneficial in thinning the mucus and coughing it out of the lungs more easily. Asthma is expected to register rapid market growth on account of the frequent pain encountered in coughing during physical activity and shortness of breath. Guaifenesin is used in combination with ephedrine to provide symtomaptic relief in patients suffering with asthma.

Guaifenesin Market Size by Clinical Application

To know more about the study, request a report sample

Hospital pharmacy is currently dominating the distribution channel segment for the guaifenesin market. It is imperative to note that guaifenesin is associate with severe adverse events thus it becomes mandatory for the dispensing of guaifenesin by a hospital pharmacist the negate occurrence of any side effects. Retail pharmacy are gaining positive market growth in the developing regions on account of availability of combination drug formulation containing guaifenesin as a generic and over the counter product.

The guaifenesin market research report presents the analysis of each segment from 2018 to 2027 considering 2020 as the base year for the research. The compounded annual growth rate (CAGR) for each respective segment is calculated for the forecast period from 2021 to 2027.

Historical & Forecast Period

2018-19 – Historical Year
2020 – Base Year
2021-2027 – Forecast Period

Global Guaifenesin Market Segmentation:

By Clinical Application:

Chest Congestion
Asthma

By Distribution Channel:

Hospital Pharmacy
Retail Pharmacy
Others

By Region:

North America
Europe
Asia Pacific
Latin America
Middle East & Africa

Geographic Coverage:

North America is presently leading the geography segment for the guaifenesin market. The rising prevalence of common cold infection across all age group primarily drives the market growth. According to the latest statistics presented by the Center for Disease Control and Prevention (CDC), annually there are approximately 75 million physicians visit pertaining to common cold infection in the United States, which is responsible for a healthcare burden of $ 7.7 billion per year. Additionally the presence of major players such as Pfizer, Inc., Reckitt Benckiser Group, plc, Aurohealth LLC, Strive Pharmaceuticals, Inc. etc further accentuate the market growth in the region. Europe is positioned in the 2^nd place in the regional segment on account of the rising prevalence of seasonal influenza in the European Union region which peaks in the winter season. As per the recent research citings provided by the European Commission report influenza affects approximately 5% to 15% of the population in the region. Asia Pacific is anticipated to be the fastest-growing regional segment during the forecast period. The constant rise in the seasonal influenza infection due to the monsoon and subtropical climate in the region and the flourishing generic drugs market.

Market Competition Assessment:

Some of the major players operating in the global guaifenesin market are Reckitt Benckiser Group, plc., Pfizer, Inc., AstraZeneca, Novartis AG, and GlaxoSmithKline, Plc. Companies are exploring markets by expansion, new investment, the introduction of new services, and collaboration as their preferred strategies. Players are exploring new geography through expansion and acquisition to gain a competitive advantage through joint synergy.

List of Key Companies:

Reckitt Benckiser Group, plc.
Pfizer, Inc.
Aurohealth LLC
7-Eleven, Inc.
Strive Pharmaceuticals, Inc.
AstraZeneca
Novartis AG
GlaxoSmithKline, Plc.
Procter & Gamble
McNeil Consumer Healthcare

Key Questions Answered by Guaifenesin Market Report:

Global guaifenesin market forecasts from 2021-2027
Regional guaifenesin market forecasts from 2021-2027 covering Asia-Pacific, North America, Europe, Middle East and Africa, and Latin America
Country-level forecasts from 2021-2027 covering 15 major countries from the aforementioned regions
Guaifenesin submarket forecasts from 2021-2027 covering the market by clinical application, by distribution channel, and geography
Various industry models such as SWOT analysis, Value Chain Analysis pertaining to the guaifenesin market
Analysis of the key factors driving and restraining the growth of the global, regional, and country-level guaifenesin markets from 2021-2027
Competitive Landscape and market positioning of top 10 players operating in the guaifenesin market

Table of Content:

1. Preface

1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Phase III – Expert Panel Review
1.4. Assumptions

2. Executive Summary

2.1. Global Guaifenesin Market Portraiture
2.2. Global Guaifenesin Market, by Clinical Application, 2020 (USD Mn)
2.3. Global Guaifenesin Market, by Distribution Channel, 2020 (USD Mn)
2.4. Global Guaifenesin Market, by Geography, 2020 (USD Mn)

3. Global Guaifenesin Market Analysis

3.1. Guaifenesin Market Overview
3.2. Market Inclination Insights
3.3. Market Dynamics
3.3.1. Drivers
3.3.2. Challenges
3.3.3. Opportunities
3.4. Attractive Investment Proposition
3.5. Competitive Analysis
3.6. COVID-19 Impact Analysis
3.6.1. V Shaped Recovery
3.6.2. U Shaped Recovery
3.6.3. L Shaped Recovery
3.6.4. W Shaped Recovery

4. Global Guaifenesin Market By Clinical Application, 2018 – 2027 (USD Mn)

4.1. Overview
4.2. Chest Congestion
4.3. Asthma

5. Global Guaifenesin Market By Distribution Channel, 2018 – 2027 (USD Mn)

5.1. Overview
5.2. Hospital Pharmacy
5.3. Retail Pharmacy
5.4. Others

6. North America Guaifenesin Market Analysis and Forecast, 2018 – 2027 (USD Mn)

6.1.1. Overview
6.1.2. North America Guaifenesin Market by Clinical Application (2018-2027 USD Mn)
6.1.3. North America Guaifenesin Market by Distribution Channel (2018-2027 USD Mn)
6.1.4. North America Guaifenesin Market by Country (2018-2027 USD Mn)
6.1.4.1. U.S.
6.1.4.1.1. U.S. Guaifenesin Market by Clinical Application (2018-2027 USD Mn)
6.1.4.1.2. U.S. Guaifenesin Market by Distribution Channel (2018-2027 USD Mn)
6.1.4.2. Canada
6.1.4.2.1. Canada Guaifenesin Market by Clinical Application (2018-2027 USD Mn)
6.1.4.2.2. Canada Guaifenesin Market by Distribution Channel (2018-2027 USD Mn)

7. Europe Guaifenesin Market Analysis and Forecast, 2018 – 2027 (USD Mn)

7.1.1. Overview
7.1.2. Europe Guaifenesin Market by Clinical Application (2018-2027 USD Mn)
7.1.3. Europe Guaifenesin Market by Distribution Channel (2018-2027 USD Mn)
7.1.4. Europe Guaifenesin Market by Country (2018-2027 USD Mn)
7.1.4.1. Germany
7.1.4.1.1. Germany Guaifenesin Market by Clinical Application (2018-2027 USD Mn)
7.1.4.1.2. Germany Guaifenesin Market by Distribution Channel (2018-2027 USD Mn)
7.1.4.2. U.K.
7.1.4.2.1. U.K. Guaifenesin Market by Clinical Application (2018-2027 USD Mn)
7.1.4.2.2. U.K. Guaifenesin Market by Distribution Channel (2018-2027 USD Mn)
7.1.4.3. France
7.1.4.3.1. France Guaifenesin Market by Clinical Application (2018-2027 USD Mn)
7.1.4.3.2. France Guaifenesin Market by Distribution Channel (2018-2027 USD Mn)
7.1.4.4. Italy
7.1.4.4.1. Italy Guaifenesin Market by Clinical Application (2018-2027 USD Mn)
7.1.4.4.2. Italy Guaifenesin Market by Distribution Channel (2018-2027 USD Mn)
7.1.4.5. Rest of Europe
7.1.4.5.1. Rest of Europe Guaifenesin Market by Clinical Application (2018-2027 USD Mn)
7.1.4.5.2. Rest of Europe Guaifenesin Market by Distribution Channel (2018-2027 USD Mn)

8. Asia Pacific Guaifenesin Market Analysis and Forecast, 2018 – 2027 (USD Mn)

8.1.1. Overview
8.1.2. Asia Pacific Guaifenesin Market by Clinical Application (2018-2027 USD Mn)
8.1.3. Asia Pacific Guaifenesin Market by Distribution Channel (2018-2027 USD Mn)
8.1.4. Asia Pacific Guaifenesin Market by Country (2018-2027 USD Mn)
8.1.4.1. China
8.1.4.1.1. China Guaifenesin Market by Clinical Application (2018-2027 USD Mn)
8.1.4.1.2. China Guaifenesin Market by Distribution Channel (2018-2027 USD Mn)
8.1.4.2. Japan
8.1.4.2.1. Japan Guaifenesin Market by Clinical Application (2018-2027 USD Mn)
8.1.4.2.2. Japan Guaifenesin Market by Distribution Channel (2018-2027 USD Mn)
8.1.4.3. Rest of Asia Pacific
8.1.4.3.1. Rest of Asia Pacific Guaifenesin Market by Clinical Application (2018-2027 USD Mn)
8.1.4.3.2. Rest of Asia Pacific Guaifenesin Market by Distribution Channel (2018-2027 USD Mn)

9. Latin America (LATAM) Guaifenesin Market Analysis and Forecast, 2018 – 2027 (USD Mn)

9.1.1. Overview
9.1.2. Latin America Guaifenesin Market by Clinical Application (2018-2027 USD Mn)
9.1.3. Latin America Guaifenesin Market by Distribution Channel (2018-2027 USD Mn)
9.1.4. Latin America Guaifenesin Market by Country (2018-2027 USD Mn)
9.1.4.1. Brazil
9.1.4.1.1. Brazil Guaifenesin Market by Clinical Application (2018-2027 USD Mn)
9.1.4.1.2. Brazil Guaifenesin Market by Distribution Channel (2018-2027 USD Mn)
9.1.4.2. Mexico
9.1.4.2.1. Mexico Guaifenesin Market by Clinical Application (2018-2027 USD Mn)
9.1.4.2.2. Mexico Guaifenesin Market by Distribution Channel (2018-2027 USD Mn)
9.1.4.3. Rest of Latin America
9.1.4.3.1. Rest of Latin America Guaifenesin Market by Clinical Application (2018-2027 USD Mn)
9.1.4.3.2. Rest of Latin America Guaifenesin Market by Distribution Channel (2018-2027 USD Mn)

10. Middle East and Africa Guaifenesin Market Analysis and Forecast, 2018 – 2027 (USD Mn)

10.1.1. Overview
10.1.2. MEA Guaifenesin Market by Clinical Application (2018-2027 USD Mn)
10.1.3. MEA Guaifenesin Market by Distribution Channel (2018-2027 USD Mn)
10.1.4. Middle East and Africa Guaifenesin Market, by Country (2018-2027 USD Mn)
10.1.4.1. GCC
10.1.4.1.1. GCC Guaifenesin Market by Clinical Application (2018-2027 USD Mn)
10.1.4.1.2. GCC Guaifenesin Market by Distribution Channel (2018-2027 USD Mn)
10.1.4.2. Rest of MEA
10.1.4.2.1. Rest of MEA Guaifenesin Market by Clinical Application (2018-2027 USD Mn)
10.1.4.2.2. Rest of MEA Guaifenesin Market by Distribution Channel (2018-2027 USD Mn)

11. Company Profiles

11.1. Reckitt Benckiser Group, plc.
11.1.1. Business Description
11.1.2. Financial Health and Budget Allocation
11.1.3. Product Positions/Portfolio
11.1.4. Recent Development
11.1.5. SWOT Analysis
11.2. Pfizer, Inc.
11.2.1. Business Description
11.2.2. Financial Health and Budget Allocation
11.2.3. Product Positions/Portfolio
11.2.4. Recent Development
11.2.5. SWOT Analysis
11.3. Aurohealth LLC
11.3.1. Business Description
11.3.2. Financial Health and Budget Allocation
11.3.3. Product Positions/Portfolio
11.3.4. Recent Development
11.3.5. SWOT Analysis
11.4. 7-Eleven, Inc.
11.4.1. Business Description
11.4.2. Financial Health and Budget Allocation
11.4.3. Product Positions/Portfolio
11.4.4. Recent Development
11.4.5. SWOT Analysis
11.5. Strive Pharmaceuticals, Inc.
11.5.1. Business Description
11.5.2. Financial Health and Budget Allocation
11.5.3. Product Positions/Portfolio
11.5.4. Recent Development
11.5.5. SWOT Analysis
11.6. AstraZeneca
11.6.1. Business Description
11.6.2. Financial Health and Budget Allocation
11.6.3. Product Positions/Portfolio
11.6.4. Recent Development
11.6.5. SWOT Analysis
11.7. Novartis AG
11.7.1. Business Description
11.7.2. Financial Health and Budget Allocation
11.7.3. Product Positions/Portfolio
11.7.4. Recent Development
11.7.5. SWOT Analysis
11.8. GlaxoSmithKline, Plc.
11.8.1. Business Description
11.8.2. Financial Health and Budget Allocation
11.8.3. Product Positions/Portfolio
11.8.4. Recent Development
11.8.5. SWOT Analysis
11.9. Procter & Gamble
11.9.1. Business Description
11.9.2. Financial Health and Budget Allocation
11.9.3. Product Positions/Portfolio
11.9.4. Recent Development
11.9.5. SWOT Analysis
11.10. McNeil Consumer Healthcare
11.10.1. Business Description
11.10.2. Financial Health and Budget Allocation
11.10.3. Product Positions/Portfolio
11.10.4. Recent Development
11.10.5. SWOT Analysis

Fill the given form to inquiry before buying for Guaifenesin Market Report

(Additional country analysis and conmapny analysis will be added according to the request, we provide free report customization)
(Report covers the impact of COVID-19 on the market)

Request Report Sample

Inquiry Before Buying

Schedule a Call

Select License Type

$ 3600/- Single User License
$ 6995/- Corporate License